German mammography screening program: adherence, characteristics of (non-)participants and utilization of non-screening mammography-a longitudinal analysis
- PMID: 37653487
- PMCID: PMC10469853
- DOI: 10.1186/s12889-023-16589-5
German mammography screening program: adherence, characteristics of (non-)participants and utilization of non-screening mammography-a longitudinal analysis
Abstract
Background: In Germany, all women aged 50-69 have been invited to biennial mammography screening since 2009. We aimed to assess longitudinal adherence over ten years in women aged 50 in 2009 and characterize the different adherence groups.
Methods: Using the German Pharmacoepidemiological Research Database (GePaRD, ~ 20% of the German population), we included women aged 50 in 2009 (baseline) with continuous health insurance coverage and without breast cancer or in-situ-carcinoma. We followed them until age 59 and categorized them according to mammography screening participation into the following groups: never, 1-2, 3-4, 5-6 times. We characterized these groups, inter alia, regarding the use of other preventive measures, non-screening mammography (i.e., mammography outside the organized screening program) and menopausal hormone therapy.
Results: Overall, 82,666 women were included. Of these, 27.6% never participated in the screening program, 15.1% participated 1-2 times, 31.7% participated 3-4 times and 25.6% participated regularly (5-6 times). Among regular participants, 91% utilized other preventive measures (e.g., cervical cancer screening, general health checkup) before baseline as compared to 66% among non-participants. Menopausal hormone therapy was least common among non-participants (11% vs. 18% among regular participants). Among non-participants, the proportions using ≥ 1, ≥ 2, and ≥ 3 non-screening mammographies between age 50-59 were 25%, 18%, and 15%, respectively.
Conclusions: Using a large cohort based on claims data, this study provides novel insights into longitudinal adherence to the mammography screening program and the use of mammography outside of the program in Germany. Between age 50-59, 57% of eligible women participated at least three times in the German mammography screening program and 28% (~ 3 in 10 women) never participated. Among non-participants, 15% had at least three non-screening mammographies during this period, indicating potential gray screening. Participants more often utilized other preventive measures as compared to non-participants.
Keywords: Adherence; Breast cancer screening; Claims data; Comorbidity; Gray screening; Longitudinal study; Mammography.
© 2023. BioMed Central Ltd., part of Springer Nature.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
German mammography screening program: program sensitivity between 2010 and 2016 estimated based on German health claims data.BMC Cancer. 2023 Sep 11;23(1):852. doi: 10.1186/s12885-023-11378-0. BMC Cancer. 2023. PMID: 37697304 Free PMC article.
-
Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.APMIS Suppl. 1998;83:1-44. APMIS Suppl. 1998. PMID: 9850674
-
Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program.Breast Cancer Res Treat. 2012 Aug;135(1):291-9. doi: 10.1007/s10549-012-2162-x. Epub 2012 Jul 26. Breast Cancer Res Treat. 2012. PMID: 22833199 Free PMC article.
-
[Cancer screening in Germany: availability and participation].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Dec;61(12):1491-1499. doi: 10.1007/s00103-018-2842-8. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018. PMID: 30406892 Review. German.
-
[Mammography screening in Germany].Radiologe. 2008 Jan;48(1):17-25. doi: 10.1007/s00117-007-1558-9. Radiologe. 2008. PMID: 18030441 Review. German.
Cited by
-
Cancer Screening: Present Recommendations, the Development of Multi-Cancer Early Development Tests, and the Prospect of Universal Cancer Screening.Cancers (Basel). 2024 Mar 18;16(6):1191. doi: 10.3390/cancers16061191. Cancers (Basel). 2024. PMID: 38539525 Free PMC article. Review.
-
Sociodemographic inequalities in breast cancer screening attendance in Germany following the implementation of an Organized Screening Program: Scoping Review.BMC Public Health. 2024 Aug 14;24(1):2211. doi: 10.1186/s12889-024-19673-6. BMC Public Health. 2024. PMID: 39143595 Free PMC article.
References
-
- Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M, et al. The benefits and harms of breast cancer screening: an independent review: a report jointly commissioned by Cancer Research UK and the Department of Health (England) October 2012. Br J Cancer. 2013;108(11):2205–2240. doi: 10.1038/bjc.2013.177. - DOI - PMC - PubMed
-
- Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013(1):Cd001877. - PubMed
-
- International Agency for Research on Cancer (IARC) Breast Cancer Screening. Lyon: IARC; 2016.